Literature DB >> 11138788

The role of chemokines in the immunopathology of the liver.

C L Bone-Larson1, K J Simpson, L M Colletti, N W Lukacs, S C Chen, S Lira, S L Kunkel, C M Hogaboam.   

Abstract

Chemokines are small protein inflammatory mediators that were classically known for their elicitation of inflammatory cells out of the vasculature. However, more contemporary studies show that these ubiquitous factors impinge on many facets of biology, including hematopoiesis, angiogenesis, and mitogeneis. The elucidation of mechanisms involved in the immunopathogenesis of liver disease has magnified the importance of chemokines in this organ. Accordingly, a number of in vitro and in vivo studies have highlighted the importance of chemokine biology in both acute and chronic liver disease, and a variety of liver diseases have been shown to involve chemokines and their receptors during the initiation and main tenance of liver pathology. A greater understanding of the role chemokines play during liver disease may permit the employment of therapies that target or enhance chemokines in the liver. This review will highlight the current clinical and experimental research in the immunopathogenesis of acute and chronic liver diseases.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11138788     DOI: 10.1034/j.1600-065x.2000.17703.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  21 in total

1.  Nuclear factor kB activity in patients with acute severe cholangitis.

Authors:  Jian-Ping Gong; Chong-An Liu; Chuan-Xin Wu; Sheng-Wei Li; Yu-Jun Shi; Xu-Hong Li
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

2.  Nutrigenomic analysis of the protective effects of bilberry anthocyanin-rich extract in apo E-deficient mice.

Authors:  Aurelie Mauray; Catherine Felgines; Christine Morand; Andrzej Mazur; Augustin Scalbert; Dragan Milenkovic
Journal:  Genes Nutr       Date:  2010-03-01       Impact factor: 5.523

3.  Role of T lymphocytes in liver abscess formation by Bacteroides fragilis in mice.

Authors:  Doo Ryeon Chung; Hye-Rim Park; Chung-Gyu Park; Eung-Soo Hwang; Chang-Yong Cha
Journal:  Infect Immun       Date:  2011-03-28       Impact factor: 3.441

4.  Intestinal damage mediated by Kupffer cells in rats with endotoxemia.

Authors:  Jian-Ping Gong; Chuan-Xin Wu; Chang-An Liu; Sheng-Wei Li; Yu-Jun Shi; Kang Yang; Yue Li; Xu-Hong Li
Journal:  World J Gastroenterol       Date:  2002-10       Impact factor: 5.742

5.  Temporal expression of chemokines dictates the hepatic inflammatory infiltrate in a murine model of schistosomiasis.

Authors:  Melissa L Burke; Donald P McManus; Grant A Ramm; Mary Duke; Yuesheng Li; Malcolm K Jones; Geoffrey N Gobert
Journal:  PLoS Negl Trop Dis       Date:  2010-02-09

6.  CXCR3 axis in patients with primary biliary cirrhosis: a possible novel mechanism of the effect of ursodeoxycholic acid.

Authors:  P Manousou; G Kolios; I Drygiannakis; M Koulentaki; K Pyrovolaki; A Voumvouraki; G Notas; L Bourikas; H A Papadaki; E Kouroumalis
Journal:  Clin Exp Immunol       Date:  2013-04       Impact factor: 4.330

7.  Nitric oxide and MCP-1 regulation in LPS activated rat Kupffer cells.

Authors:  George Kolios; Vassilis Valatas; Pinelopi Manousou; Costas Xidakis; George Notas; Elias Kouroumalis
Journal:  Mol Cell Biochem       Date:  2008-07-16       Impact factor: 3.396

8.  Complement-dependent inflammation and injury in a murine model of brain dead donor hearts.

Authors:  Carl Atkinson; Juan C Varela; Stephen Tomlinson
Journal:  Circ Res       Date:  2009-10-08       Impact factor: 17.367

9.  Octreotide regulates CC but not CXC LPS-induced chemokine secretion in rat Kupffer cells.

Authors:  Vassilis Valatas; George Kolios; Pinelopi Manousou; George Notas; Costas Xidakis; Ioannis Diamantis; Elias Kouroumalis
Journal:  Br J Pharmacol       Date:  2004-01-12       Impact factor: 8.739

10.  Hepatic expression of CCL2 in alcoholic liver disease is associated with disease severity and neutrophil infiltrates.

Authors:  D Degré; A Lemmers; T Gustot; R Ouziel; E Trépo; P Demetter; L Verset; E Quertinmont; V Vercruysse; O Le Moine; J Devière; C Moreno
Journal:  Clin Exp Immunol       Date:  2012-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.